Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases[E8]
UnknownEuropean Commission[E1]
- Cierra[E2]
- Plazo del financiador: 17 feb 2027, 01:00 hora de Europa central (UTC+1). UTC: 17 feb 2027, 00:00 UTC.
- Financiación total[E9]
- EUR 10.000.000
- Idioma de la oferta
- Tu idioma
- Tu encaje
- Inicia sesión para ver tu encaje
En palabras sencillas
- Qué financia
- Escribiendo un breve resumen en tu idioma…
- Quién puede solicitar
- EU grant rules apply: check the call conditions for who can apply, consortium rules and co-funding.
- Abierta a: Universities and research
- Fase: Prototype and MVP
- Bases y solicitud
Las bases, normas y el formulario de solicitud están en la página del financiador. Léalos antes de solicitar.
Riesgos e incógnitas
- RiesgoThis is a grant, not a contract. Grants usually need a proposal against the funder's criteria, may need partners and often need co-funding.[E5]
- DesconocidoWe read the funder's listing, not the full guidance or application forms.
- Abre[E6]
- 29 oct 2026
- Última comprobación
- hace 11 horas
Sobre la financiación · Del anuncio
Call: Cluster 1 - Health (Two stage - 2027). Type of action: HORIZON Research and Innovation Actions. Expected Outcome: This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Developing and using new tools, technologies and digital solutions for a healthy society”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to all the following expected outcomes: Clinical researchers and developers have access to novel predictive biomarkers to guide a more accurate assessment of disease progression and treatment response and tackle the unmet clinical needs of non-communicable chronic diseases. Clinicians and healthcare professionals use clinically validated predictive biomarkers for implementing more effective clinical research and personalised medicine with better health outcomes in chronic non-communicable diseases. Key stakeholders have access to trustworthy Artificial Intelligence (AI) tools to guide the development of multimodal predictive biomarkers of higher accuracy and clinical value when compared to the established practice. The citizens benefit of better health outcomes thanks to improved clinical guidelines and the implementation of effective biomarker-guided clinical research and personalised healthcare. Scope: Biomarkers [1] are invaluable tools for improving patient outcomes, guiding treatment decisions, accelerating personalised medicine, more effective clinical research and the development of better medicines. However, des…[E3]
Quién puede solicitar
- Abierta aUniversities and research. Etiquetado por SLETOR a partir del texto de la convocatoria.
- CondiciónEU grant rules apply: check the call conditions for who can apply, consortium rules and co-funding.[E4]
Financiador
Qué más ofrece este financiadorEuropean Commission
La convocatoria no da otra vía de contacto con el financiador aparte de la página original.
Cómo hacer una pregunta
Haga sus preguntas en la página o la vía de consulta del financiador. Lea antes la guía. Abrir la vía del comprador
Solo mostramos la vía de contacto de la propia organización tal como se publica: su web, su plataforma, buzones compartidos y teléfonos principales. Nunca una persona.
Pruebas9 datos del anuncio · MostrarOcultar
Cada dato de esta página procede de la convocatoria del financiador. Cada entrada muestra el registro y el campo del que se leyó.
- E1
The funder is European Commission.
De Development of predictive biomarkers of disease progression and treatment respo… (ID HORIZON-HLTH-2027-02-TOOL-01-two-stage), campo /metadata/type/0, leído 29 oct 2026, 07:41 UTC · fuente (se abre en una pestaña nueva)
- E2
Proposals must be submitted by 17 Feb 2027, 01:00 Central European time (UTC+1).
“2027-02-17T00:00:00.000+0000”
De Development of predictive biomarkers of disease progression and treatment respo… (ID HORIZON-HLTH-2027-02-TOOL-01-two-stage), campo /metadata/deadlineDate/0, leído 29 oct 2026, 07:41 UTC · fuente (se abre en una pestaña nueva)
- E3
The buyer describes the requirement in the notice.
“Expected Outcome: This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Developing and using new tools, technologies and digital solutions for a healthy society”. To that end, proposals under this topic shou…”
De Development of predictive biomarkers of disease progression and treatment respo… (ID HORIZON-HLTH-2027-02-TOOL-01-two-stage), campo /metadata/descriptionByte/0, leído 29 oct 2026, 07:41 UTC · fuente (se abre en una pestaña nueva)
- E4
EU grant rules apply: check the call conditions for who can apply, consortium rules and co-funding.
“EU call topic”
De Development of predictive biomarkers of disease progression and treatment respo… (ID HORIZON-HLTH-2027-02-TOOL-01-two-stage), campo /metadata/type/0, leído 29 oct 2026, 07:41 UTC · fuente (se abre en una pestaña nueva)
- E5
This is an EU call for proposals.
“31094502”
De Development of predictive biomarkers of disease progression and treatment respo… (ID HORIZON-HLTH-2027-02-TOOL-01-two-stage), campo /metadata/status/0, leído 29 oct 2026, 07:41 UTC · fuente (se abre en una pestaña nueva)
- E6
Applications open on 29 Oct 2026.
“2026-10-29T00:00:00.000+0000”
De Development of predictive biomarkers of disease progression and treatment respo… (ID HORIZON-HLTH-2027-02-TOOL-01-two-stage), campo /metadata/startDate/0, leído 29 oct 2026, 07:41 UTC · fuente (se abre en una pestaña nueva)
- E7
The Funding & Tenders Portal gives the status as open for submission.
De Development of predictive biomarkers of disease progression and treatment respo… (ID HORIZON-HLTH-2027-02-TOOL-01-two-stage), campo /metadata/status/0, leído 29 oct 2026, 07:41 UTC · fuente (se abre en una pestaña nueva)
- E8
The notice is titled "Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases".
De Development of predictive biomarkers of disease progression and treatment respo… (ID HORIZON-HLTH-2027-02-TOOL-01-two-stage), campo /metadata/title/0, leído 29 oct 2026, 07:41 UTC · fuente (se abre en una pestaña nueva)
- E9
The EU contribution per grant is up to EUR 10,000,000 (from EUR 5,000,000).
De Development of predictive biomarkers of disease progression and treatment respo… (ID HORIZON-HLTH-2027-02-TOOL-01-two-stage), campo /metadata/budgetOverview/0, leído 29 oct 2026, 07:41 UTC · fuente (se abre en una pestaña nueva)
Source: EU Funding & Tenders Portal, © European Union, CC BY 4.0. SLETOR shortened and reformatted the text. Licencia de datos: Creative Commons Attribution 4.0 (European Commission) (se abre en una pestaña nueva). No guardamos ni mostramos los datos de contacto personales de los anuncios.
Actualizaciones
Abierta a ofertas · 29 oct 2026, 07:41 UTC
The funder published the call with a future closing date.
Cambios: status, notice type, published at (registro de origen Development of predictive biomarkers of disease progression and treatment respo… (ID HORIZON-HLTH-2027-02-TOOL-01-two-stage))
Vista por primera vez · 28 oct 2026, 21:22 UTC
The funder announced the call. Applications have not opened yet.
Registro de origen: Development of predictive biomarkers of disease progression and treatment respo… (ID HORIZON-HLTH-2027-02-TOOL-01-two-stage)